"10.1371_journal.pone.0022370","plos one","2011-07-28T00:00:00Z","Federico T Bianchi; Paola Camera; Ugo Ala; Daniele Imperiale; Antonio Migheli; Enrica Boda; Filippo Tempia; Gaia Berto; Ylenia Bosio; Salvatore Oddo; Frank M LaFerla; Stefano Taraglio; Carlos G Dotti; Ferdinando Di Cunto","Department of Genetics, Biology and Biochemistry, Molecular Biotechnology Center, University of Torino, Torino, Italy; Centro DOMP, Azienda Ospedaliera ASL-TO2, Torino, Italy; Department of Neurosciences, University of Torino, Torino, Italy; Department of Physiology, University of Texas Health Science Center, San Antonio, Texas, United States of America; Department of Neurobiology and Behavior, Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, California, United States of America; VIB Department of Molecular and Developmental Genetics and Katholieke Universiteit Leuven, Department of Human Genetics, Leuven, Belgium","Conceived and designed the experiments: FTB DI AM EB FDC. Performed the experiments: FTB DI EB PC GB YB. Analyzed the data: FTB UA FDC. Contributed reagents/materials/analysis tools: FT SO FML ST CGD. Wrote the paper: FTB FDC.","The authors have read the journals policy and have the following conflicts: The University of Turin has deposited a patent application on the use of HSP47 inhibitors as lead compounds for AD, on the behalf of Ferdinando Di Cunto and Federico T. Bianchi. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","07","Federico T Bianchi","FTB",14,TRUE,5,6,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
